Royal Dsm – IL BIOECONOMISTA

DSM boosts maternal and infant nutrition portfolio with new plant-based DHA oil

18 May 202018 May 2020Il BioeconomistaLeave a comment

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a purpose-led, global science-based company active in Nutrition, Health and Sustainable Living, launched its new, high-quality life’sDHA® SF55-O200DS oil for maternal and early life nutrition solutions. Offering a higher potency, this ingredient contains a minimum of 550 mg/g natural triglyceride DHA (docosahexaenoic acid), allowing manufacturers to achieve equivalent dosages of DHA in smaller product formats and meet the latest maternal nutrition trend for convenient capsule and tablet sizes.

Continue reading →

DSM completed its acquisition of Glycom to grow in the Early Life Nutrition solutions

6 April 2020Il BioeconomistaLeave a comment

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, completed its acquisition of Glycom A/S, the world’s leading supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of €765 million.

Continue reading →

DSM, Sabic and UPM Biofuels partner for a transition to renewable resources

13 March 202012 March 2020Il BioeconomistaLeave a comment

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, Sabic, a global leader in the chemical industry, and UPM Biofuels, a leading producer of sustainable raw materials, signed a partnership that will help to reduce the environmental footprint of Dyneema®, the world’s strongest fiber. The collaboration will see Dyneema® transition to bio-based feedstock leveraging SABIC’s ground-breaking TRUCIRCLETM solutions for certified renewable products. As such, DSM is delivering on its commitment to improve the sustainability footprint of Dyneema®, moving towards a circular, bio-based economy.

Continue reading →

The biobased self-mattin resin developed by Royal DSM takes a step forward

13 January 202011 January 2020Il BioeconomistaLeave a comment

Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces that its new, bio-based self-matting resin, Decovery® SP-2022 XP, has been successfully integrated by coating formulators Ciranova and Arboritec AB into products launched at Domotex 2020. As such, the resin is now successfully enabling easier application and higher aesthetic and functional performance in the flooring market, as well as outperforming conventional market alternatives on sustainability.

Continue reading →

Amyis fully exited its Vitamin E business

24 April 201923 April 2019Il BioeconomistaLeave a comment

Amyris, a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, sold its Vitamin E royalty agreement to Koninklijke DSM N.V. (Royal DSM). This agreement assigns Amyris’s rights to Vitamin E royalties to DSM in exchange for total consideration of approximately $57 million. In addition, DSM and Amyris have agreed to a further manufacturing cooperation for Amyris products at DSM’s Brotas facility that provides additional capacity and lower cost of goods sold with an expected approximate aggregate benefit of $30–$40 million over the next three years. The expected economic benefit of both agreements to Amyris is approximately $90 million.

Continue reading →

The JV Reverdia will be dissolved effective 1 April 2019

22 February 201922 February 2019Il BioeconomistaLeave a comment

Effective 1 April 2019, the joint venture between Royal DSM and Roquette, Reverdia, will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium^® plant in Cassano, Italy to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium^®. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium^® technology, will assume the role of exclusive licensor, in line with its business model in this field.

Continue reading →

Royal DSM creates a JV with Nenter to fulfill its future need for Vitamine E

30 January 201929 January 2019Il BioeconomistaLeave a comment

Royal DSM, a Dutch global science-based company in Nutrition, Health and Sustainable Living, intends to create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenter’s production and related assets for Vitamin E.

Continue reading →

Tour de France: Royal DSM partners with Team Sunweb. A natural ingredient can reduce the toxic effects of exercise by more than half

9 July 20187 July 2018Il BioeconomistaLeave a comment

Royal DSM, the Dutch global science-based company in Nutrition, Health and Sustainable Living, is helping professional cyclists Team Sunweb to recover faster in this year’s Tour de France with its dietary antiplatelet, Fruitflow®. This forms part of the innovation partnership between DSM and Team Sunweb that aims to improve the health, nutrition and cycling materials of the professional athletes.

Continue reading →

DSM continues to invest in the biofuel industry

29 March 201828 March 2018Il BioeconomistaLeave a comment

Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.

Continue reading →

Eight promising bioeconomy start-ups pitched in Delft at an event organized by Royal DSM

9 October 20177 October 2017Il BioeconomistaLeave a comment

A total of eight promising start-ups were invited to pitch at the event “Connecting Bright Innovations 2017” organised by Royal DSM and held this year in Delft (Netherlands), which focused on new and innovative products and biotechnologies for food, health and (bio)tech applications. A panel of expert venturing and innovation specialists is evaluating the pitches with a view to their suitability for further financing and partnering opportunities.

Continue reading →